Compare Enzyme (MLN) vs Tria (TRIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Tria — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Tria trades at Rp144.43 (market cap Rp311,65M, Rp40,65M 24h volume). The key difference: Tria is far larger — about 2.3× Enzyme's market cap, and Tria's supply is capped (2,2B / 10B TRIA (22%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Tria for 4 Days on average.
| MLN | TRIA | |
|---|---|---|
Market Cap | Rp134,13M | Rp311,65M |
Volume (24h) | Rp104,56M | Rp40,65M |
Circulating Supply | 3,3M MLN | 2,2B / 10B TRIA (22%) |
Typical Hold Time | 29 Days | 4 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
TRIA is trading at Rp150.352 with a market cap of Rp323.76M and a neutral technical signal. The token shows balanced momentum with RSI and ADX indicators in neutral to slightly positive zones, while support and resistance levels indicate a tight trading range. With only 22% of the max supply in circulation and a short average hold time of 4 days, liquidity and volatility are key considerations. No major protocol updates or ecosystem news were identified recently.
Overall outlook is neutral with potential for short-term range-bound trading. Key opportunities include low float dynamics if demand increases, but risks are high due to low liquidity, regulatory uncertainty in crypto markets, and minimal fundamental developments. Investors should monitor exchange volume and on-chain activity for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Tria
Tria is a self-custodial crypto neobank and cross-chain routing engine that enables seamless spending, trading, and earning within one application. It addresses blockchain fragmentation through its BestPath routing technology, enabling gasless, bridge-free transactions and card payments directly from user-controlled wallets. The TRIA token supports rewards, ecosystem access, and governance participation.
Read more on TRIA →
